Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Berlind Life Science AB
AB
Active
Org 5591504161
Åkerövägen 4
Engineering activities and related technical consultancy · NACE 7112
Est. 2018
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 2,6M
-17% vs 2024
EBITDA margin
40.3%
-39% vs 2024
Equity ratio
57.4%
Financial strength
Net profit 2025
SEK 639K
-42% vs 2024
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
1M
2021
1M
0%
2022
2M
+100%
2023
2M
0%
2024
1M
-50%
2025
Key figures
Annual report 2025
Revenue
SEK 2,6M
-17%
EBITDA
SEK 1M
-39%
Net profit
SEK 639K
-42%
Total assets
SEK 4,3M
+8%
Equity
SEK 2,4M
+16%
Employees
1
—
Company information
Legal name
Berlind Life Science AB
Org number
5591504161
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
26 februari 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom Life Science
Contact
Address
Åkerövägen 4
Email
berndtssonlinda.c@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Ängelholm
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
2M
2021
2M
2022
2M
2023
3M
2024
3M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
1M
2021
1M
2022
2M
2023
2M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 584
1 962
2 429
3 084
2 567
Staff expenses
—
−941
−904
−1 042
—
EBITDA
560
719
1 628
1 692
1 035
Depreciation & amort.
−0
—
—
—
−0
EBIT
560
719
1 628
1 692
1 035
Net financials
—
0
23
50
57
Profit before tax
420
535
1 236
1 398
812
Tax
−87
−114
−257
−295
−173
Net profit
333
421
979
1 103
639
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
958
1 376
2 518
3 939
4 261
Equity
462
604
1 303
2 106
2 444
Long-term debt
0
—
—
—
0
Short-term debt
225
319
346
620
324
Total debt
225
319
346
620
324
Financial ratios
5-year trend
EBITDA margin
40.3%
This company
15.8%
Market median
+155% vs market
2021
2025
Equity ratio
57.4%
This company
38.2%
Market median
+50% vs market
2021
2025
Return on equity
26.1%
This company
18.4%
Market median
+42% vs market
2021
2025
Net profit margin
24.9%
This company
8.1%
Market median
+207% vs market
2021
2025
Asset turnover
0.60×
This company
1.12×
Market median
-46% vs market
2021
2025
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LC
Linda Christin Berndtsson
Board of Directors
2022
MC
Maria Camilla Berndtsson
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Berlind Life Science AB also hold positions in
0
other companies.
Person
Role here
Other companies
Linda Christin Berndtsson
Board of Directors
0 companies
Maria Camilla Berndtsson
Deputy Board Member
0 companies